Lisa, S.A. argues dividend non-enforceability and judicial embargoes to defeat extinctive prescription claim
Oct 28 2025
Lisa, S.A.
Lisa, S.A., through its judicial representative Rossana Mishelle Ramírez Paredes, filed its closing argument for the oral hearing scheduled for October 28, 2025, before the Fourteenth Multi-Judge Civil Court of First Instance in Guatemala, in the summary proceeding for extinctive prescription of dividends (Expediente 01164-2022-01230) brought by Avícola Las Margaritas, S.A. (successor by merger of Compañía Alimenticia de Centroamérica, S.A.). The brief constitutes Lisa's comprehensive defense against the attempt to extinguish by prescription the obligation to pay dividends decreed at the Annual General Shareholders' Meeting of November 17, 2016, and requests that the claim be denied and five peremptory exceptions sustained. This argument was filed after the party declaration hearing of October 23, 2024, in which Avícola Las Margaritas' representative admitted the existence of embargoes on Lisa's dividends.
The plaintiff, Avícola Las Margaritas, S.A., seeks a declaration that the obligation to pay dividends decreed at the Annual General Shareholders' Meeting of Compañía Alimenticia de Centroamérica, S.A. on November 17, 2016, is time-barred. That meeting approved the distribution of profits from the 2015 fiscal year at a rate of Q.1,520.00 per share. Avícola Las Margaritas contends that shareholders could demand payment the day after the meeting and that, having failed to do so, the obligation prescribed under Article 1508 of the Civil Code.
Lisa, S.A. answered the complaint in the negative and raised peremptory exceptions. The ruling of July 10, 2023 sustained the preliminary exception of failure of condition and rejected the prescription claim in first instance. The proceeding continued through the evidentiary phase, culminating in the oral hearing for which this closing argument was filed.
Avícola Las Margaritas, S.A. argues that dividends became enforceable the day after the November 17, 2016 meeting and that more than five years elapsed without Lisa, S.A. taking any action to collect them, thus triggering extinctive prescription under Article 1508 of the Civil Code.
Lisa argues that the plaintiff's claim lacks factual and legal support. The November 17, 2016 Assembly resolution did not set a payment date or method but expressly authorized the administration to make payment "in the form and when it deems appropriate." Clause sixteen, subsection d) of the company's articles of incorporation (public deed number 166) grants the Board of Directors the power to "determine the date and form of payment of approved profits." Until the Board exercised that power, the obligation was not enforceable, and under Article 1509 of the Civil Code the prescription period could not begin to run.
Lisa contends that Article 675 of the Commercial Code, which makes obligations without a contractual term immediately enforceable, is inapplicable because the obligation arises not from a bilateral mercantile contract but from a corporate resolution that expressly established a suspensive condition. The dies a quo for the prescription period never occurred.
Lack of truthfulness in the constitutive facts of the alleged prescription. The notarial act transcribing the Assembly resolution, produced by the plaintiff itself, disproves the claim of immediate enforceability by establishing a deferred enforceability conditioned on a subsequent act of administration.
Failure of legal prerequisites for prescription to operate. The obligation was subject to a suspensive condition under Articles 1269 and 1592 of the Civil Code. Without a Board resolution fixing the date, form, and mechanism of payment, the legal moment to begin the prescription period never arose.
Lack of free disposition over embargoed dividends. The dividends were and remain subject to precautionary embargoes decreed in multiple proceedings. The administration of the plaintiff company assumed the status of judicial depositary of the retained funds. Under Article 304 of the Civil Procedural Code, once an embargo is notified, the debtor cannot pay the judgment debtor. The letter of November 8, 2018, on the letterhead of Compañía Alimenticia de Centroamérica, S.A. and signed by its Vice President, expressly acknowledged that payment was impossible due to judicial embargoes. Lisa characterizes the attempt to prescribe an obligation frozen by judicial mandate as a misuse of the institution, incompatible with good faith and akin to fraud upon the law.
The party declaration by Avícola Las Margaritas confirmed that the Shareholder Registry contains more than five precautionary embargo annotations on dividends and amounts that could correspond to Lisa, S.A.
Injury to third-party rights. The dividends form part of an embargoed asset pool securing claims by third parties in pending proceedings. Declaring prescription would undermine the purpose of the precautionary measures and the priority rights they protect.
Interruption of prescription. Even if the obligation had been enforceable, the period was interrupted under Article 1506 of the Civil Code by multiple judicial and extrajudicial actions, including notarial demands of February 28, 2017 and October 31, 2018, and the company's express acknowledgment on November 8, 2018 that payment was impossible.
Lisa identifies and refutes the plaintiff's three principal pieces of evidence:
In support of its defense, Lisa relies on the notarial demands of 2017 and 2018, and the November 8, 2018 letter in which the company itself acknowledged that embargoes prevented payment.